223 related articles for article (PubMed ID: 16979946)
21. Open-Capsule Budesonide for Refractory Celiac Disease.
Mukewar SS; Sharma A; Rubio-Tapia A; Wu TT; Jabri B; Murray JA
Am J Gastroenterol; 2017 Jun; 112(6):959-967. PubMed ID: 28323276
[TBL] [Abstract][Full Text] [Related]
22. DNAM-1 mediates epithelial cell-specific cytotoxicity of aberrant intraepithelial lymphocyte lines from refractory celiac disease type II patients.
Tjon JM; Kooy-Winkelaar YM; Tack GJ; Mommaas AM; Schreurs MW; Schilham MW; Mulder CJ; van Bergen J; Koning F
J Immunol; 2011 Jun; 186(11):6304-12. PubMed ID: 21525383
[TBL] [Abstract][Full Text] [Related]
23. Molecular analysis of T-cell clonality in ulcerative jejunitis and enteropathy-associated T-cell lymphoma.
Ashton-Key M; Diss TC; Pan L; Du MQ; Isaacson PG
Am J Pathol; 1997 Aug; 151(2):493-8. PubMed ID: 9250161
[TBL] [Abstract][Full Text] [Related]
24. The Intracellular Intensity of CD3 on Aberrant Intraepithelial Lymphocytes Is a Prognostic Factor of the Progression to Overt Lymphoma in Refractory Celiac Disease Type II (Pre-Enteropathy-Associated T Cell Lymphoma).
García-Hoz C; Crespo L; Lopez N; De Andrés A; Ríos León R; Santón A; Garriga M; Butz E; León F; Roy Ariño G
Dig Dis; 2020; 38(6):490-499. PubMed ID: 32015237
[TBL] [Abstract][Full Text] [Related]
25. Azathioprine in refractory sprue: results from a prospective, open-label study.
Mauriño E; Niveloni S; Cherñavsky A; Pedreira S; Mazure R; Vazquez H; Reyes H; Fiorini A; Smecuol E; Cabanne A; Capucchio M; Kogan Z; Bai JC
Am J Gastroenterol; 2002 Oct; 97(10):2595-602. PubMed ID: 12385445
[TBL] [Abstract][Full Text] [Related]
26. Flow cytometric analysis of intestinal intraepithelial lymphocytes in the diagnosis of refractory celiac sprue.
Sanchez-Muñoz LB; Santón A; Cano A; Lopez A; Almeida J; Orfao A; Escribano L; Roy G
Eur J Gastroenterol Hepatol; 2008 May; 20(5):478-87. PubMed ID: 18403953
[TBL] [Abstract][Full Text] [Related]
27. Immunohistochemical and T-cell receptor gene rearrangement analyses as predictors of morbidity and mortality in refractory celiac disease.
Arguelles-Grande C; Brar P; Green PH; Bhagat G
J Clin Gastroenterol; 2013 Aug; 47(7):593-601. PubMed ID: 23470642
[TBL] [Abstract][Full Text] [Related]
28. Recent advances in refractory coeliac disease: a review.
Ho-Yen C; Chang F; van der Walt J; Mitchell T; Ciclitira P
Histopathology; 2009 Jun; 54(7):783-95. PubMed ID: 18700844
[TBL] [Abstract][Full Text] [Related]
29. Dendritic cells promote expansion and survival of aberrant TCR-negative intraepithelial lymphocyte lines from refractory celiac disease type II patients.
Schmitz F; Tjon JM; van Bergen J; Koning F
Mol Immunol; 2014 Mar; 58(1):10-6. PubMed ID: 24252355
[TBL] [Abstract][Full Text] [Related]
30. CD20+ T-cell lymphoma: clinicopathologic analysis of 9 cases and a review of the literature.
Rahemtullah A; Longtine JA; Harris NL; Dorn M; Zembowicz A; Quintanilla-Fend L; Preffer FI; Ferry JA
Am J Surg Pathol; 2008 Nov; 32(11):1593-607. PubMed ID: 18753947
[TBL] [Abstract][Full Text] [Related]
31. Azathioprine and prednisone combination therapy in refractory coeliac disease.
Goerres MS; Meijer JW; Wahab PJ; Kerckhaert JA; Groenen PJ; Van Krieken JH; Mulder CJ
Aliment Pharmacol Ther; 2003 Sep; 18(5):487-94. PubMed ID: 12950421
[TBL] [Abstract][Full Text] [Related]
32. The value of double-balloon enteroscopy in patients with refractory celiac disease.
Hadithi M; Al-toma A; Oudejans J; van Bodegraven AA; Mulder CJ; Jacobs M
Am J Gastroenterol; 2007 May; 102(5):987-96. PubMed ID: 17378908
[TBL] [Abstract][Full Text] [Related]
33. 18F-FDG PET versus CT for the detection of enteropathy-associated T-cell lymphoma in refractory celiac disease.
Hadithi M; Mallant M; Oudejans J; van Waesberghe JH; Mulder CJ; Comans EF
J Nucl Med; 2006 Oct; 47(10):1622-7. PubMed ID: 17015897
[TBL] [Abstract][Full Text] [Related]
34. Continual monitoring of intraepithelial lymphocyte immunophenotype and clonality is more important than snapshot analysis in the surveillance of refractory coeliac disease.
Liu H; Brais R; Lavergne-Slove A; Jeng Q; Payne K; Ye H; Liu Z; Carreras J; Huang Y; Bacon CM; Hamoudi RA; Save V; Venkatraman L; Isaacson PG; Woodward J; Du MQ
Gut; 2010 Apr; 59(4):452-60. PubMed ID: 19996326
[TBL] [Abstract][Full Text] [Related]
35. Origin and immunophenotype of aberrant IEL in RCDII patients.
Tack GJ; van Wanrooij RL; Langerak AW; Tjon JM; von Blomberg BM; Heideman DA; van Bergen J; Koning F; Bouma G; Mulder CJ; Schreurs MW
Mol Immunol; 2012 Apr; 50(4):262-70. PubMed ID: 22364936
[TBL] [Abstract][Full Text] [Related]
36. A pilot study of 2-chloro-2'-deoxyadenosine in the treatment of systemic lupus erythematosus-associated glomerulonephritis.
Davis JC; Austin H; Boumpas D; Fleisher TA; Yarboro C; Larson A; Balow J; Klippel JH; Scott D
Arthritis Rheum; 1998 Feb; 41(2):335-43. PubMed ID: 9485092
[TBL] [Abstract][Full Text] [Related]
37. Clinical staging and survival in refractory celiac disease: a single center experience.
Rubio-Tapia A; Kelly DG; Lahr BD; Dogan A; Wu TT; Murray JA
Gastroenterology; 2009 Jan; 136(1):99-107; quiz 352-3. PubMed ID: 18996383
[TBL] [Abstract][Full Text] [Related]
38. Budesonide in the treatment of refractory celiac disease.
Brar P; Lee S; Lewis S; Egbuna I; Bhagat G; Green PH
Am J Gastroenterol; 2007 Oct; 102(10):2265-9. PubMed ID: 17581265
[TBL] [Abstract][Full Text] [Related]
39. Reduced chemokine receptor 9 on intraepithelial lymphocytes in celiac disease suggests persistent epithelial activation.
Olaussen RW; Karlsson MR; Lundin KE; Jahnsen J; Brandtzaeg P; Farstad IN
Gastroenterology; 2007 Jun; 132(7):2371-82. PubMed ID: 17570212
[TBL] [Abstract][Full Text] [Related]
40. Impact of cladribine therapy on changes in circulating dendritic cell subsets, T cells and B cells in patients with multiple sclerosis.
Mitosek-Szewczyk K; Tabarkiewicz J; Wilczynska B; Lobejko K; Berbecki J; Nastaj M; Dworzanska E; Kolodziejczyk B; Stelmasiak Z; Rolinski J
J Neurol Sci; 2013 Sep; 332(1-2):35-40. PubMed ID: 23835090
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
